Key result
Synchronized DC cardioversion successfully terminates supraventricular tachycardia in an infant with Wolff-Parkinson-White syndrome.
Why the study?
Wolff–Parkinson–White syndrome is a congenital cardiac conduction abnormality with supraventricular tachycardia as the most common associated arrhythmia, requiring prompt intervention in infants.
Case Report (n=1)
Highlights the use of synchronized DC cardioversion for life-threatening SVT in an infant with WPW syndrome.
May guide acute SVT management in infants with WPW; leaves open prospective data on pediatric cardioversion protocols.
Wolff–Parkinson–White (WPW) syndrome is a congenital abnormality of the cardiac conducting system. In the general population, its prevalence is 0.15%–0.3%, with supraventricular tachycardia (SVT) being the most common rhythm disorder associated with it. SVT is the most common cardiac arrhythmia in children that requires therapy. It occurs because an accessory conduction pathway allows atrioventricular impulses to reenter the normal conduction pathway, thus completing a circuit that stimulates the atrium and ventricle at a rapid rate. Symptoms are nonspecific but could be life-threatening in infants, necessitating prompt intervention and prophylaxis. Cardioversion by pharmacologic or synchronized direct current (DC) is indicated in life-threatening or refractory arrhythmias. We report a 16-month-old Nigerian girl who had WPW syndrome and developed SVT that required synchronized DC cardioversion.
No takes yet. Share an insight, caveat, or question.
Folayan et al. (2022) conducted a case report in Wolff-Parkinson-White syndrome with supraventricular tachycardia (n=1). Synchronized DC cardioversion was evaluated. Synchronized DC cardioversion was required to treat supraventricular tachycardia in a 16-month-old girl with Wolff-Parkinson-White syndrome.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: